Results of a randomized phase II study of two schedules of bryostatin-I in patients with malignant melanoma: experience with the multivariate stopping rule Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Belanger, K
  • Tozer, Richard
  • Burdette-Radoux, S
  • Davis, M
  • Lohmann, R
  • Zee, B
  • Wainman, N
  • Seymour, L

publication date

  • September 1999